Human brucellosis is characterized by an intense Th1 profile associated with a defective monocyte function.
In animal models, a defective Th1 response appears to be critical in the pathogenesis of brucellosis, but the Th1 response in human brucellosis patients remains partially undefined. Peripheral blood from 24 brucellosis patients was studied before and 45 days after antibiotherapy. Twenty-four sex- and age-matched healthy donors were analyzed in parallel. Significantly increased levels of interleukin 1beta (IL-1beta), IL-2, IL-4, IL-6, IL-12p40, gamma interferon (IFN-gamma), and tumor necrosis factor alpha (TNF-alpha), but not of IL-10, in serum and/or significantly increased percentages of samples with detectable levels of these cytokines, measured by enzyme-linked immunosorbent assays (ELISA), were found for untreated brucellosis patients, but these levels were reduced and/or normalized after treatment. Flow cytometry studies showed that the intracytoplasmic expression of IFN-gamma, IL-2, and TNF-alpha, but not that of IL-4, by phorbol myristate-activated CD4(+) CD3(+) and CD8(+) CD3(+) T lymphocytes was significantly increased in untreated brucellosis patients and was also partially normalized after antibiotherapy. The percentage of phagocytic cells, the mean phagocytic activity per cell, and the phagocytic indices for monocytes at baseline were defective and had only partially reverted at follow-up. T lymphocytes from untreated brucellosis patients are activated in vivo and show Th1 cytokine production polarization, with strikingly high serum IFN-gamma levels. In spite of this Th1 environment, we found deficient effector phagocytic activity in peripheral blood monocytes.
Rodríguez-Zapata
Manuel
M
Laboratorio de Enfermedades del Sistema Inmune y Oncología, Unidad Asociada al CNB-CSIC, Universidad de Alcalá, Madrid, Spain.
Matías
Marlene J
MJ
Prieto
Alfredo
A
Jonde
Marco A
MA
Monserrat
Jorge
J
Sánchez
Lorenzo
L
Reyes
Eduardo
E
De la Hera
Antonio
A
Alvarez-Mon
Melchor
M
D000328:Adult; D000368:Aged; D002006:Brucellosis / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007371:Interferon-gamma / Q000097:blood; D016753:Interleukin-10 / Q000097:blood; D018664:Interleukin-12 / Q000097:blood; D053583:Interleukin-1beta / Q000097:blood; D007376:Interleukin-2 / Q000097:blood; D015847:Interleukin-4 / Q000097:blood; D015850:Interleukin-6 / Q000097:blood; D008213:Lymphocyte Activation / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009000:Monocytes / Q000276:immunology*; D018417:Th1 Cells / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000097:blood; D055815:Young Adult
D053583:Interleukin-1beta; D007376:Interleukin-2; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10; D018664:Interleukin-12; D015847:Interleukin-4; D007371:Interferon-gamma
Immunology. 2001 Aug;103(4):511-8
11529943
PLoS One. 2009 Jun 16;4(6):e5893
19529776
J Immunol. 2007 Apr 15;178(8):5182-91
17404301
Enferm Infecc Microbiol Clin. 1992 Jan;10(1):43-8
1498175
N Engl J Med. 2005 Jun 2;352(22):2325-36
15930423
PLoS One. 2007 Jul 18;2(7):e631
17637846
Am J Trop Med Hyg. 1999 Sep;61(3):425-7
10497984
Infect Immun. 1992 Oct;60(10):4407-9
1398950
Int Surg. 1998 Jan-Mar;83(1):24-7
9706511
Vet Microbiol. 2002 Dec 20;90(1-4):383-94
12414158
Vet Microbiol. 2002 Dec 20;90(1-4):367-82
12414157
Adv Immunol. 2007;96:41-101
17981204
Dev Biol Stand. 1984;56:107-12
6436087
Infect Immun. 2005 Dec;73(12):8418-24
16299342
Res Microbiol. 2006 Mar;157(2):93-8
16364608
Lancet Infect Dis. 2006 Feb;6(2):91-9
16439329
Infect Immun. 1995 Mar;63(3):1130-3
7868238
Eur J Clin Invest. 1996 Feb;26(2):136-40
8904523
Curr Opin Microbiol. 2004 Feb;7(1):93-7
15036147
FEMS Immunol Med Microbiol. 2005 Aug 1;45(2):253-8
15949930
Wien Klin Wochenschr. 1994;106(8):250-2
8023517
Scand J Clin Lab Invest Suppl. 1968;97:77-89
4179068
Emerg Infect Dis. 1997 Apr-Jun;3(2):213-21
9204307
PLoS Pathog. 2008 Feb 8;4(2):e21
18266466
J Clin Microbiol. 2009 Jul;47(7):2084-9
19420176
J Immunol. 1989 Nov 15;143(10):3330-7
2509555
Vet Res. 2005 May-Jun;36(3):313-26
15845228
J Hepatol. 2004 Apr;40(4):624-31
15030978
Clin Infect Dis. 1992 Nov;15(5):764-70
1445973
J Immunol. 2008 Jan 15;180(2):1080-7
18178848
J Immunol. 2006 Oct 15;177(8):5533-9
17015740
Mol Microbiol. 2004 May;52(3):621-30
15101970
J Leukoc Biol. 2005 May;77(5):652-60
15668339
Immunobiology. 2008;213(3-4):367-75
18406381
Immunol Cell Biol. 2008 Jul;86(5):398-408
18392044
Indian J Med Microbiol. 2007 Oct;25(4):387-90
18087091
Clin Microbiol Rev. 2003 Jan;16(1):65-78
12525425
Clin Microbiol Rev. 2000 Oct;13(4):615-50
11023961
J Immunol. 1997 Aug 15;159(4):1767-74
9257839
J Leukoc Biol. 2008 Dec;84(6):1462-71
18772281
Infection. 2002 Jan;30(1):33-4
11876513
Infect Immun. 1990 Jan;58(1):254-6
2104599
J Infect Dis. 2002 Jul 15;186(2):252-9
12134263
Infect Immun. 1993 Nov;61(11):4899-901
8406893
Vet Immunol Immunopathol. 1990 Oct;26(2):171-82
2124401
Scand J Immunol. 1998 Nov;48(5):459-68
9822252
J Appl Microbiol. 2005;98(6):1270-81
15916641
J Infect. 2008 Nov;57(5):397-403
18834635
Microbes Infect. 2003 Jun;5(7):621-7
12787738
Infect Immun. 2001 Oct;69(10):6541-4
11553603
Clin Infect Dis. 2006 May 1;42(9):1266-73
16586386
Cell Mol Life Sci. 2003 Nov;60(11):2334-46
14625680